Published Date: 26 Apr 2023
In a preclinical study, a novel method of CAR T-cell therapy against small cell lung cancer (SCLC) has shown great promise. Our knowledge of CAR T has been expanded by the findings.
Read Full News1.
Study finds common genetic target may halt breast cancer cell growth
2.
More pain, more gain? New biopsy technique found to improve prostate cancer detection
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
An effective treatment for a rare but deadly form of cancer
5.
Atezolizumab + Cabozantinib Postpones mCRPC Progression.
1.
Unravelling the Mysteries of Monoclonal Gammopathy
2.
Unlocking the Secret to Accurate ANC Calculation with This Informative Blog Post
3.
Value, Access, and Affordability in Next-Gen Oncology: Navigating Costs, Coverage, and Clinical Impact
4.
The Risk Factors of Venous Thromboembolism and How to Lower Your Chances
5.
Personalized Cancer Vaccines and Neoantigen mRNA: A New Era in Oncology
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
Should We Use DARA Up Front As First-Line Therapy in MM?
2.
Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma
3.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
4.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
5.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation